加藤元康 (Motoyasu Kato) - マイポータル

基本情報

所属: 順天堂大学呼吸器内科

J-GLOBAL ID: 202401014714097160
researchmap会員ID: R000076981

論文

Hyperprogressive disease under anti-PD-1 rechallenge after initial response to anti-PD-1 treatment for non-small cell lung cancer: a case report.

Shiting Xu, Takehito Shukuya, Shoko Shimamura, Takuo Hayashi, Yoshihiko Sato, Hitomi Shiozaki, Toshihiko Nishioki, Koichi Nishino, Motoyasu Kato, Aritoshi Hattori …

Translational lung cancer research 13(3) 666-672 2024年3月29日
Extrapleural air secondary to idiopathic pulmonary fibrosis-related pneumomediastinum.

Yuichi Nagata, Takayasu Watanabe, Yuki Tanabe, Motoyasu Kato, Takehito Shukuya, Kuniaki Seyama, Kazuhisa Takahashi

Respirology case reports 12(1) e01271 2024年1月
Trifluridine and Tipiracil Hydrochloride Combination-Induced Interstitial Pneumonia: A Case Report.

Shun Nakazawa, Motoyasu Kato, Yuriko Terayama, Naho Sakamoto Matubara, Yoshihiko Sato, Ryoko Murashima, Daisuke Hayakawa, Shouichi Okamoto, Kazuhisa Takahashi

International medical case reports journal 17 101-104 2024年
A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib.

Masaki Okamoto, Kiminori Fujimoto, Takeshi Johkoh, Atsushi Kawaguchi, Hiroshi Mukae, Noriho Sakamoto, Takashi Ogura, Satoshi Ikeda, Yasuhiro Kondoh, Yasuhiko Yamano …

Scientific reports 13(1) 22977-22977 2023年12月27日
Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world.

Motoyasu Kato, Shinichi Sasaki, Wataru Mori, Makiko Kohmaru, Takashi Akimoto, Eri Hayakawa, Soichiro Soma, Yuta Arai, Naho Sakamoto Matsubara, Shun Nakazawa …

Scientific reports 13(1) 12528-12528 2023年8月2日
Pneumatosis intestinalis with free air in the abdominal cavity caused by nintedanib.

Naho Sakamoto, Motoyasu Kato, Toshihiko Oni, Yuriko Terayama, Shun Nakazawa, Shouichi Okamoto, Jun Ito, Kazuhisa Takahashi

Respirology case reports 11(3) e01085 2023年3月
Nationwide retrospective observational study of idiopathic dendriform pulmonary ossification: clinical features with a progressive phenotype.

Yasuhiko Nishioka, Yuko Toyoda, Ryoko Egashira, Takeshi Johkoh, Yasuhiro Terasaki, Akira Hebisawa, Kinya Abe, Tomohisa Baba, Yuji Fujikura, Etsuo Fujita …

BMJ open respiratory research 9(1) 2022年9月
Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias.

Noriyuki Enomoto, Sakae Homma, Naohiko Inase, Yasuhiro Kondoh, Takeshi Saraya, Hajime Takizawa, Yoshikazu Inoue, Hiroshi Ishii, Yoshio Taguchi, Shinyu Izumi …

Thorax 77(2) 143-153 2022年2月
Idiopathic dendriform pulmonary ossification diagnosed by bronchoscopic lung cryobiopsy: A case report.

Yasuhito Sekimoto, Yuichi Nagata, Motoyasu Kato, Yuta Arai, Yuichi Fujimoto, Haruhi Takagi, Takehiko Shukuya, Takuo Hayashi, Tetsutaro Nagaoka, Yasuko Yoshioka …

Respirology case reports 10(2) e0896 2022年2月
Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan.

Shu Hisata, Masashi Bando, Sakae Homma, Kensuke Kataoka, Takashi Ogura, Shinyu Izumi, Susumu Sakamoto, Kizuku Watanabe, Yoshinobu Saito, Yasuo Shimizu …

Respiratory investigation 59(6) 819-826 2021年11月
Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case report.

Motoyasu Kato, Mikiko Mori, Keita Miura, Tetsuhiko Asao, Hiroaki Motomura, Koichi Nishino, Ryo Ko, Ryo Koyama, Takuo Hayashi, Kazuhisa Takahashi

Thoracic cancer 12(22) 3076-3079 2021年11月
Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma.

Kazuhiko Nakagawa, Takashi Kijima, Morihito Okada, Masahiro Morise, Motoyasu Kato, Katsuya Hirano, Nobukazu Fujimoto, Mitsuhiro Takenoyama, Hiroshi Yokouchi, Yuichiro Ohe …

JTO clinical and research reports 2(6) 100178-100178 2021年6月
Zinc-finger E-box-binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib.

Fariz Nurwidya, Fumiyuki Takahashi, Wira Winardi, Ken Tajima, Yoichiro Mitsuishi, Akiko Murakami, Isao Kobayashi, Takeshi Nara, Muneaki Hashimoto, Motoyasu Kato …

Thoracic cancer 12(10) 1536-1548 2021年5月
Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial.

Susumu Sakamoto, Kensuke Kataoka, Yasuhiro Kondoh, Motoyasu Kato, Masaki Okamoto, Hiroshi Mukae, Masashi Bando, Takafumi Suda, Kazuhiro Yatera, Yoshinori Tanino …

The European respiratory journal 57(1) 2021年1月
Clinical Significance of Continuable Treatment with Nintedanib Over 12 Months for Idiopathic Pulmonary Fibrosis in a Real-World Setting.

Motoyasu Kato, Shinichi Sasaki, Misa Tateyama, Yuta Arai, Hiroaki Motomura, Issei Sumiyoshi, Yusuke Ochi, Junko Watanabe, Hiroaki Ihara, Shinsaku Togo …

Drug design, development and therapy 15 223-230 2021年
Atezolizumab-induced fulminant type 1 diabetes mellitus occurring four months after treatment cessation.

Toshihiko Nishioki, Motoyasu Kato, Shunichi Kataoka, Keita Miura, Tetsutaro Nagaoka, Kazuhisa Takahashi

Respirology case reports 8(9) e00685 2020年12月
Hermansky-Pudlak syndrome-associated pneumothorax with rapid progression of respiratory failure: a case report.

Yukari Kato, Motoyasu Kato, Hiroaki Ihara, Eri Hayakawa, Kohei Shibayama, Keita Miura, Tomoko Yamada, Yoichiro Mitsuishi, Takehito Shukuya, Jun Ito …

BMC pulmonary medicine 20(1) 259-259 2020年10月6日
Author Correction: Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis.

Motoyasu Kato, Shinichi Sasaki, Takahiro Nakamura, Kana Kurokawa, Tomoko Yamada, Yusuke Ochi, Hiroaki Ihara, Fumiyuki Takahashi, Kazuhisa Takahashi

Scientific reports 10(1) 12080-12080 2020年7月16日
Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway.

Hiroaki Ihara, Yoichiro Mitsuishi, Motoyasu Kato, Fumiyuki Takahashi, Ken Tajima, Takuo Hayashi, Moulid Hidayat, Wira Winardi, Aditya Wirawan, Daisuke Hayakawa …

Respiratory investigation 58(4) 275-284 2020年7月
Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway.

Motoyasu Kato, Fumiyuki Takahashi, Tadashi Sato, Yoichiro Mitsuishi, Ken Tajima, Hiroaki Ihara, Fariz Nurwidya, Hario Baskoro, Akiko Murakami, Isao Kobayashi …

Drug design, development and therapy 14 4593-4603 2020年

もっとみる

MISC

Dasatinib suppresses TGF beta-induced epithelial mesenchymal transition and inhibits pulmonary fibrosis

Motoyasu Kato, Fumiyuki Takahashi, Shigehiro Yagishita, Tetsuhiko Asao, Ryota Kanemaru, Kentaro Suina, Hario Bascoro, Fariz Nurwidya, Isao Kobayashi, Keiko Muraki …

EUROPEAN RESPIRATORY JOURNAL 44 2014年9月査読有り
TRANILAST INHIBITS PULMONARY FIBROSIS BY SUPPRESSING TGF beta-MEDIATED EXTRACELLULAR MATRIX PROTEIN PRODUCTION

Motoyasu Kato, Fumiyuki Takahashi, Fariz Nurwirya, Tadashi Sato, Isao Kobayashi, Yoshito Hoshika, Akiko Murakami, Ryo Ko, Shigehiro Yagishita, Masataka Yoshioka …

RESPIROLOGY 18 73-73 2013年11月査読有り

共同研究・競争的資金等の研究課題

アリシンの肺線維化抑制効果の検討

日本学術振興会科学研究費助成事業基盤研究(C) 2022年4月 - 2025年3月

加藤元康, 十合晋作
上皮間葉転換を標的とした薬剤性肺障害克服の試み

日本学術振興会科学研究費助成事業基盤研究(C) 2017年4月 - 2022年3月

加藤元康, 高橋史行, 高橋和久